These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34321486)

  • 21. Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications.
    Jiang JC; Zhang Y
    Biochem Soc Trans; 2020 Dec; 48(6):2851-2863. PubMed ID: 33170924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic Bead-Based Immunoassay Allows Rapid, Inexpensive, and Quantitative Detection of Human SARS-CoV-2 Antibodies.
    Huergo LF; Selim KA; Conzentino MS; Gerhardt ECM; Santos ARS; Wagner B; Alford JT; Deobald N; Pedrosa FO; de Souza EM; Nogueira MB; Raboni SM; Souto D; Rego FGM; Zanette DL; Aoki MN; Nardin JM; Fornazari B; Morales HMP; Borges VA; Nelde A; Walz JS; Becker M; Schneiderhan-Marra N; Rothbauer U; Reis RA; Forchhammer K
    ACS Sens; 2021 Mar; 6(3):703-708. PubMed ID: 33496577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reciprocating-flowing on-a-chip enables ultra-fast immunobinding for multiplexed rapid ELISA detection of SARS-CoV-2 antibody.
    Liu Y; Tan Y; Fu Q; Lin M; He J; He S; Yang M; Chen S; Zhou J
    Biosens Bioelectron; 2021 Mar; 176():112920. PubMed ID: 33418184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies.
    Hubbard JA; Geno KA; Khan J; Szczepiorkowski ZM; de Gijsel D; Ovalle AA; AlSalman AS; Gallagher TL; Johnston AA; Tibbetts AR; Vital SE; Cervinski MA; Nerenz RD
    J Appl Lab Med; 2021 Mar; 6(2):429-440. PubMed ID: 32976593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
    Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y
    J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Validation of a Multiplex, Bead-based Assay to Detect Antibodies Directed Against SARS-CoV-2 Proteins.
    Bray RA; Lee JH; Brescia P; Kumar D; Nong T; Shih R; Woodle ES; Maltzman JS; Gebel HM
    Transplantation; 2021 Jan; 105(1):79-89. PubMed ID: 33273320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Turning Antibodies into Ratiometric Bioluminescent Sensors for Competition-Based Homogeneous Immunoassays.
    van Aalen EA; Lurvink JJJ; Vermeulen L; van Gerven B; Ni Y; Arts R; Merkx M
    ACS Sens; 2024 Mar; 9(3):1401-1409. PubMed ID: 38380622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System.
    Angeloni S; Cameron A; Pecora ND; Dunbar S
    J Vis Exp; 2021 Apr; (170):. PubMed ID: 33900295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interlaboratory Agreement of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serologic Assays in the Expedited College of American Pathologists Proficiency Testing Program.
    Tacker DH; Bashleben C; Long TC; Theel ES; Knight V; Kadkhoda K; Rhoads DD; Linden MA; Fink SL
    Arch Pathol Lab Med; 2021 May; 145(5):536-542. PubMed ID: 33461214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advancing Luciferase-Based Antibody Immunoassays to Next-Generation Mix and Read Testing.
    Burbelo PD; Ji Y; Iadarola MJ
    Biosensors (Basel); 2023 Feb; 13(3):. PubMed ID: 36979515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
    Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
    Front Public Health; 2020; 8():620222. PubMed ID: 33681115
    [No Abstract]   [Full Text] [Related]  

  • 32. A Next-Generation Rapid, Accurate SARS-CoV-2 Antibody Test.
    Abbasi J
    JAMA; 2021 May; 325(18):1825. PubMed ID: 33974035
    [No Abstract]   [Full Text] [Related]  

  • 33. Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers.
    Mullins KE; Merrill V; Ward M; King B; Rock P; Caswell M; Ahlman M; Harris AD; Christenson R
    Clin Biochem; 2021 Apr; 90():23-27. PubMed ID: 33472036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Production Lots of a Rapid Point-of-Care Lateral Flow Serological Test Intended for Identification of IgM and IgG against the N-Terminal Part of the Spike Protein (S1) of SARS-CoV-2.
    Hoffman T; Kolstad L; Rönnberg B; Lundkvist Å
    Viruses; 2021 May; 13(6):. PubMed ID: 34072890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodies.
    Parai D; Dash GC; Choudhary HR; Peter A; Rout UK; Nanda RR; Kshatri JS; Kanungo S; Pati S; Bhattacharya D
    J Virol Methods; 2021 Jun; 292():114121. PubMed ID: 33684402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Immunofluorescence Assay for the Rapid Serological Detection of SARS-CoV-2 Infection.
    Nguyen D; Skelly D; Goonawardane N
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays.
    Walker GJ; Naing Z; Ospina Stella A; Yeang M; Caguicla J; Ramachandran V; Isaacs SR; Agapiou D; Bull RA; Stelzer-Braid S; Daly J; Gosbell IB; Hoad VC; Irving DO; Pink JM; Turville S; Kelleher AD; Rawlinson WD
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective serological evaluation of anti SARS-CoV-2 IgG and anti S1-RBD antibodies in a community outbreak.
    Carta M; Bragagnolo L; Tramarin A; Cappelletti A; Barzon E; Forner L; Meneghini MG; Tripodi C; Gottardo M; Dal Lago F; Marinello S; Dal Grande G; Pascarella M; Rassu M; Giavarina D
    Clin Chem Lab Med; 2021 Jul; 59(8):e322-e325. PubMed ID: 33641271
    [No Abstract]   [Full Text] [Related]  

  • 39. Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity.
    Becker M; Strengert M; Junker D; Kaiser PD; Kerrinnes T; Traenkle B; Dinter H; Häring J; Ghozzi S; Zeck A; Weise F; Peter A; Hörber S; Fink S; Ruoff F; Dulovic A; Bakchoul T; Baillot A; Lohse S; Cornberg M; Illig T; Gottlieb J; Smola S; Karch A; Berger K; Rammensee HG; Schenke-Layland K; Nelde A; Märklin M; Heitmann JS; Walz JS; Templin M; Joos TO; Rothbauer U; Krause G; Schneiderhan-Marra N
    Nat Commun; 2021 Feb; 12(1):1152. PubMed ID: 33608538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays.
    Tang MS; Case JB; Franks CE; Chen RE; Anderson NW; Henderson JP; Diamond MS; Gronowski AM; Farnsworth CW
    Clin Chem; 2020 Dec; 66(12):1538-1547. PubMed ID: 32894750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.